Express Scripts released new data showing significantly improved clinical outcomes and reduced drug spending for diabetes. In its inaugural year, the Diabetes Care Value program, part of the technology-supported, value-based SafeGuardRx platform, reduced diabetes drug spending by 19% – $360 per member per year – for the more than 800 plan sponsors enrolled in the program, delivering a total savings of $42.6M in 2017. In addition, Express Scripts diabetes specialist pharmacists, using advanced clinical analytics, improved compliance with recommended treatment guidelines by starting an additional 15% of enrolled patients at risk for heart attack or stroke on statin therapy. If all Express Scripts plans were to similarly increase statin use among their members with diabetes for better cholesterol control, they could prevent an estimated 13,000 heart attacks over the next 10 years.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.